![]()
|
|
||||||||
J. Biol. Chem., Vol. 276, Issue 21, 17641-17652, May 25, 2001
| ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
From the Biotechnology Centre of Oslo, University of Oslo,
Oslo 0316, Norway
TCF11 is a bZIP transcription factor of
the CNC subfamily. It has been implicated in the regulation of the
antioxidant response and is vital during embryonic development, but its
precise biological functions have not yet been fully worked out.
Structural characterization of the gene and several of its products
indicates that complex regulatory mechanisms are employed. To
investigate how altering the structure of the gene products might
influence their activity we have mapped functional domains within the
protein. We show that two separate domains are required for
transactivation by full-length TCF11: an N-terminal acidic domain and a
serine-rich stretch adjacent to the CNC-bZIP domains. A naturally
occurring shorter isoform (identical to LCR-F1) produced by internal
initiation of translation is unable to transactivate in our assay.
However, the shorter form could interfere with the transactivating
ability of the longer form, which indicates a control mechanism for
keeping the activity of TCF11 at a desired level. We show that TCF11
and the closely related CNC-bZIP factor p45 NF-E2 show different cell type-specific activation patterns with full-length TCF11 being active
in COS-1 cells but silent in erythroid cells (K562), whereas p45 NF-E2
is active in K562 cells and silent in COS-1 cells. Domain swapping
experiments show that cell type-specific activity is not fully
determined by dimerization/DNA binding domains or transactivation domains alone. The resulting profile of activity is most likely achieved by interaction of the domains and their cell-specific environment.
Two Domains of the Human bZIP Transcription Factor TCF11 Are
Necessary for Transactivation*
*
The costs of publication of this
article were defrayed in part by the
payment of page charges. The article
must therefore be hereby marked
"advertisement" in
accordance with 18 U.S.C. Section
1734 solely to indicate this fact.
To whom correspondence should be addressed: Biotechnology Centre
of Oslo, University of Oslo, 1125 Blindern, 0316 Oslo, Norway. Tel.: 47-22840510; Fax: 47-22840501; E-mail:
annebko@biotek.uio.no.
This article has been cited by other articles:
![]() |
W. Wang and J. Y. Chan Nrf1 Is Targeted to the Endoplasmic Reticulum Membrane by an N-terminal Transmembrane Domain: INHIBITION OF NUCLEAR TRANSLOCATION AND TRANSACTING FUNCTION J. Biol. Chem., July 14, 2006; 281(28): 19676 - 19687. [Abstract] [Full Text] [PDF] |
||||
![]() |
K. Narayanan, A. Ramachandran, M. C. Peterson, J. Hao, A.-B. Kolsto, A. D. Friedman, and A. George The CCAAT Enhancer-binding Protein (C/EBP){beta} and Nrf1 Interact to Regulate Dentin Sialophosphoprotein (DSPP) Gene Expression during Odontoblast Differentiation J. Biol. Chem., October 29, 2004; 279(44): 45423 - 45432. [Abstract] [Full Text] [PDF] |
||||
![]() |
R. Valgardsdottir and H. Prydz Transport Signals and Transcription-dependent Nuclear Localization of the Putative DEAD-box Helicase MDDX28 J. Biol. Chem., May 30, 2003; 278(23): 21146 - 21154. [Abstract] [Full Text] [PDF] |
||||
| HOME | HELP | FEEDBACK | SUBSCRIPTIONS | ARCHIVE | SEARCH | TABLE OF CONTENTS |
| All ASBMB Journals | Molecular and Cellular Proteomics |
| Journal of Lipid Research | ASBMB Today |